73P - Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study
Autor: | He, A.R., Weiss, G.J., Falchook, G., Yee, N.S., Gil-Martin, M., Shahda, S., Moreno, V., Brana, I., Crittenden, M., Formenti, S., Al-Rajabi, R., Papadopoulos, K.P., Pishvaian, M.J., Stankevich, E., Feng, M., Li, J., Mathias, M., Kroog, G., Lowy, I., Fury, M.G. |
---|---|
Zdroj: | In Annals of Oncology December 2018 29 Supplement 10:x26-x26 |
Databáze: | ScienceDirect |
Externí odkaz: |